(S (NP (NP (NNP Physicians)) (VP (VBG taking) (NP (NP (NN care)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN coronavirus) (NN disease) (PRN (-LRB- -LRB-) (NP (NN COVID) (HYPH -) (CD 19)) (-RRB- -RRB-))))))))) (VP (VBP have) (VP (VBN described) (NP (JJ different) (NNS changes)) (PP (IN in) (NP (JJ routine) (NN blood) (NNS parameters))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (DT these) (NNS changes)) (, ,) (VP (VB hinder) (NP (PRP them)) (PP (IN from) (S (VP (VBG performing) (NP (NML (NNP COVID) (HYPH -) (CD 19)) (NN diagnosis)))))) (. .))
(S (NP (PRP We)) (VP (VBD constructed) (NP (DT a) (NN machine)) (S (VP (VBG learning) (NP (JJ predictive) (NN model)) (PP (IN for) (NP (NML (NN COVID) (HYPH -) (CD 19)) (NN diagnosis)))))) (. .))
(S (NP (DT The) (NN model)) (VP (VBD was) (VP (VBN based) (CC and) (VBN cross-validated) (PP (IN on) (NP (NP (DT the) (JJ routine) (NN blood) (NNS tests)) (PP (IN of) (NP (NP (NP (CD 5,333) (NNS patients)) (PP (IN with) (NP (JJ various) (JJ bacterial) (CC and) (JJ viral) (NNS infections)))) (, ,) (CC and) (NP (CD 160) (NNP COVID) (JJ -19-positive) (NNS patients)))))))) (. .))
(S (NP (PRP We)) (VP (VBD selected) (NP (JJ operational) (NN ROC) (NN point)) (PP (IN at) (NP (NP (NP (DT a) (NN sensitivity)) (PP (IN of) (NP (CD 81.9) (NN %)))) (CC and) (NP (NP (NN specificity)) (PP (IN of) (NP (CD 97.9) (NN %))))))) (. .))
(S (NP (NP (DT The) (JJ cross-validated) (NN area)) (PP (IN under) (NP (DT the) (NN curve) (-LRB- -LRB-) (NN AUC) (-RRB- -RRB-)))) (VP (VBD was) (NP (CD 0.97))) (. .))
(S (NP (NP (DT The) (CD five) (ADJP (RBS most) (JJ useful)) (NML (JJ routine) (NN blood)) (NNS parameters)) (PP (IN for) (NP (NN COVID19) (NN diagnosis)))) (PP (VBG according) (PP (IN to) (NP (NP (DT the) (NN feature) (NN importance) (NN scoring)) (PP (IN of) (NP (DT the) (NNP XGBoost) (NN algorithm)))))) (VP (VBD were) (NP (NP (NNP MCHC)) (, ,) (NP (NN eosinophil) (NML (NN count) (, ,) (NN albumin) (, ,) (NN INR) (, ,) (CC and) (NN prothrombin)) (NN activity) (NN percentage)))) (. .))
(S (NP (NN tSNE) (NN visualization)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (NN blood) (NNS parameters)) (PP (IN of) (NP (NP (DT the) (NNS patients)) (PP (IN with) (NP (JJ severe) (NML (NN COVID) (HYPH -) (CD 19)) (NN course)))))) (VP (VBP are) (ADVP (RBR more)) (PP (IN like) (NP (NP (DT the) (NNS parameters)) (PP (IN of) (NP (NP (JJ bacterial)) (PP (IN than) (NP (JJ viral) (NN infection))))))))))) (. .))
(S (NP (DT The) (VBN reported) (JJ diagnostic) (NN accuracy)) (VP (VBZ is) (ADJP (ADJP (ADVP (IN at) (JJS least)) (JJ comparable)) (CC and) (ADJP (RB probably) (JJ complementary))) (PP (IN to) (NP (NML (NML (NN RT) (HYPH -) (NN PCR)) (CC and) (NML (NN chest) (NN CT))) (NNS studies)))) (. .))
(S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (NN fever)) (, ,) (NP (NN cough)) (, ,) (NP (NN myalgia)) (, ,) (CC and) (NP (JJ other) (NNS symptoms))))) (VP (MD can) (ADVP (RB now)) (VP (VB have) (NP (NP (JJ initial) (JJ routine) (NN blood) (NNS tests)) (VP (VBN assessed) (PP (IN by) (NP (PRP$ our) (JJ diagnostic) (NN tool))))))) (. .))
(S (NP (NP (DT All) (NNS patients)) (PP (IN with) (NP (DT a) (ADJP (JJ positive) (NP (NN COVID) (HYPH -) (CD 19))) (NN prediction)))) (VP (MD would) (ADVP (RB then)) (VP (VB undergo) (NP (JJ standard) (NML (NN RT) (HYPH -) (NN PCR)) (NNS studies)) (S (VP (TO to) (VP (VB confirm) (NP (DT the) (NN diagnosis))))))) (. .))
(S (NP (PRP We)) (VP (VBP believe) (SBAR (IN that) (S (NP (PRP$ our) (NNS results)) (VP (VBP present) (NP (DT a) (JJ significant) (NN contribution)) (PP (IN to) (NP (NP (NNS improvements)) (PP (IN in) (NP (NML (NN COVID) (HYPH -) (CD 19)) (NN diagnosis))))))))) (. .))
